VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54.
View in:
PubMed
subject areas
Adult
Aged
Brain Neoplasms
Clinical Trials as Topic
Disease-Free Survival
Glioblastoma
Humans
Isocitrate Dehydrogenase
Middle Aged
Mutation
Neoplasm Recurrence, Local
Retrospective Studies
Young Adult
authors with profiles
JACOB MANDEL
GREGORY N FULLER
JOHN FREDERICK DE GROOT